Natco Pharma Limited


Natco Pharma Limited is a vertically integrated and R&D focused pharmaceutical company engaged in developing, manufacturing and marketing of finished dosage formulations (“FDF”) and active pharmaceutical ingredients (“APIs”) for Indian and International markets. This company manufacture and market generic medicines that comply with global standards and strive to achieve market leadership in domestic and international markets. The company’s first product was Cardicap, which is an anti–anginal drug. Since then, the company has introduced many dosage forms into the market.  Their products are manufactured in facilities that have approvals from stringent regulatory authorities like USFDA, Ministry of Health Greece, Infarmed Portugal, German Health Regulatory Authority.